The Role of Scientific Publishing in the SARS‐CoV‐2 Pandemic.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 376, doi. 10.1002/phar.2402
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2020 AND VI 40 AND IP 5
Results: 15
1
2
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 416, doi. 10.1002/phar.2398
- By:
- Publication type:
- Article
3
Considerations for Statin Therapy in Patients with COVID‐19.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 484, doi. 10.1002/phar.2397
- By:
- Publication type:
- Article
4
COVID‐19: Important Therapy Considerations and Approaches in this Hour of Need.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 379, doi. 10.1002/phar.2396
- By:
- Publication type:
- Article
5
Therapeutic Potential for Tetracyclines in the Treatment of COVID‐19.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 487, doi. 10.1002/phar.2395
- By:
- Publication type:
- Article
6
COVID‐19: The Uninvited Guest in the Intensive Care Unit — Implications for Pharmacotherapy.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 382, doi. 10.1002/phar.2394
- By:
- Publication type:
- Article
7
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non‐Fulminant Severe Clostridioides difficile Infection.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 398, doi. 10.1002/phar.2393
- By:
- Publication type:
- Article
8
Successful Treatment of Delayed Methotrexate Clearance Using Glucarpidase Dosed on Ideal Body Weight in Obese Patients.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 479, doi. 10.1002/phar.2390
- By:
- Publication type:
- Article
9
Advantages of Outpatient Treatment with Long‐Acting Lipoglycopeptides for Serious Gram‐Positive Infections: A Review.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 469, doi. 10.1002/phar.2389
- By:
- Publication type:
- Article
10
Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 438, doi. 10.1002/phar.2388
- By:
- Publication type:
- Article
11
Chloroquine and Hydroxychloroquine in the Era of SARS – CoV2: Caution on Their Cardiac Toxicity.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 387, doi. 10.1002/phar.2387
- By:
- Publication type:
- Article
12
Comparison of Hydromorphone versus Fentanyl‐based Sedation in Extracorporeal Membrane Oxygenation: A Propensity‐Matched Analysis.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 389, doi. 10.1002/phar.2385
- By:
- Publication type:
- Article
13
Effects of β2‐Adrenergic Agonists on Risk of Parkinson's Disease in COPD: A Population‐Based Study.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 408, doi. 10.1002/phar.2383
- By:
- Publication type:
- Article
14
Quality of Evidence Supporting Major Psychotropic Drug‐Drug Interaction Warnings: A Systematic Literature Review.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 455, doi. 10.1002/phar.2382
- By:
- Publication type:
- Article
15
Issue Information.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 5, p. 373, doi. 10.1002/phar.2251
- Publication type:
- Article